Filing Details

Accession Number:
0001209191-21-004142
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-19 20:32:40
Reporting Period:
2021-01-15
Accepted Time:
2021-01-19 20:32:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501756 Adverum Biotechnologies Inc. ADVM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379344 Laurent Fischer C/O Adverum Biotechnologies, Inc.
800 Saginaw Drive
Redwood City CA 94063
Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-15 8,600 $11.53 16,292 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $11.44 to $11.60. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.